Gene therapies look set to revolutionize the field of medicine – and AAVs have emerged as the vector of choice.

How can we reduce AI's energy consumption for improved drug discovery?

A new vaccine protects against type 1 diabetes in animal models.

The University of Oxford receives its first batch of AZD1222, a coronavirus vaccine candidate.

The COVID-19 pandemic has put additional supply pressures on cold-chain products, such as those encapsulated by LNPs. How can delays be avoided?

How will the ADC sector fair in 2020 and beyond?

Do pharma mergers and acquisitions improve R&D productivity and increase shareholder value?

How is the business of making medicine changing in light of the COVID-19 pandemic?

Manufacturers have a unique opportunity to take advantage of the cost and time advantages associated with Oligo(dT) – the adoption process is simple.

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.